Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VynleadsVYND 30 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates VYND with a GF Score™ of 30/100. The stock has 3 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Vynleads ranks worse than 149476.68% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vynleads's Free Cash Flow for the
three
months ended in Mar. 2026 was $-0.04 Mil. Vynleads's Revenue for the
three
months ended in Mar. 2026 was $0.00 Mil. Therefore, Vynleads's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for Vynleads's FCF Margin % or its related term are showing as below:
During the past 9 years, the highest FCF Margin % of Vynleads was -8.31%. The lowest was -235.42%. And the median was -19.80%.
VYND's FCF Margin % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 3.39 * Ranked among companies with meaningful FCF Margin % only.
Vynleads FCF Margin % Related Terms
Vynleads FCF Margin % Historical Data
* Premium members only.
The historical data trend for Vynleads's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Vynleads's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vynleads FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vynleads's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Vynleads's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vynleads (VYND) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vynleads and its competitors. According to the industry distribution chart, Vynleads ranks #999999 out of 669 companies in the Healthcare Providers & Services industry.
Is Vynleads' FCF Margin % too high?
Vynleads' current FCF Margin % is 0.00%. Based on the distribution chart, Vynleads ranks #999999 out of 669 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Vynleads has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Vynleads' FCF Margin % compare to ACON and WLSS?
According to the Healthcare Providers & Services industry distribution chart, Vynleads ranks #999999 out of 669 companies for FCF Margin %. This places Vynleads in the lower half of its industry. The industry median FCF Margin % is 3.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.39, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vynleads and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vynleads's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vynleads stock overvalued right now?
Vynleads (VYND) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Vynleads' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Vynleads (VYND), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vynleads Inc is a provider of health and wellness information principally targeted to people who are pre-diabetic or who have type 2 diabetes. It provides information to customers who are seeking to make healthy choices by providing clear, generic blueprints, education, resources, and support. Its core product is proprietary Lifestyle Blueprint, a digital guide that provides dietary recommendations for a very low calorie eight-week diet together with information focusing on what, how and how much a person eats, nutritional information and how a person's body does and does not use food for a more successful lifestyle. It also offers nutritional supplements and monthly subscriptions to its proprietary newsletter which covers a wide variety of healthy living-related topics.
30GF Score
Get the complete analysis for VYND
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VYND has been successfully added to your 
